Labcorp Holdings Inc (BSP:L1CA34)
R$ 309.8 0 (0%) Market Cap: 103.65 Bil Enterprise Value: 139.66 Bil PE Ratio: 44.11 PB Ratio: 2.33 GF Score: 78/100

Laboratory Corporation of America Holdings at Robert W Baird Global Healthcare Conference Transcript

Sep 09, 2020 / 03:25PM GMT
Release Date Price: R$239.99
Eric White Coldwell
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst

Okay. Good morning, everyone. This is Eric Coldwell. I'm Baird's Healthcare Supply Chain and Pharma Services analyst, and it's our pleasure today to have LabCorp with us presenting in the room. As you can see, we have Clarissa Willett, VP of IR; Glenn Eisenberg, EVP and CFO; and also Adam Schechter, Chairman and CEO.

To get started, we're going to have Adam kick us off with a few comments, and then we'll go straight into the fireside chat. Adam?

Adam H. Schechter
Laboratory Corporation of America Holdings - President, CEO & Chairman

Yes. Thank you, Eric. It's good to see you, and we appreciate you having us here today. I wish we could be with you in person. Obviously, we can't do that at the moment. But we're committed to talking with you, to talking about LabCorp, the issues that we face, but also the great strides that we've made as we've gone through COVID-19. And as we continue to implement our overall strategy.

I'll be making

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot